These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 15578730)
1. p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma. Di Vinci A; Perdelli L; Banelli B; Salvi S; Casciano I; Gelvi I; Allemanni G; Margallo E; Gatteschi B; Romani M Int J Cancer; 2005 Apr; 114(3):414-21. PubMed ID: 15578730 [TBL] [Abstract][Full Text] [Related]
2. Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Liu T; Niu Y; Feng Y; Niu R; Yu Y; Lv A; Yang Y Hum Pathol; 2008 Nov; 39(11):1637-46. PubMed ID: 18657295 [TBL] [Abstract][Full Text] [Related]
3. [Methylation and expression of gene p16INK4a and RB in breast carcinoma]. Zhao YF; Shen SP; Jiang JY; Geng H; Guo JG; Xie LP Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):377-81. PubMed ID: 21055153 [TBL] [Abstract][Full Text] [Related]
4. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Breuer RH; Snijders PJ; Sutedja GT; Sewalt RG; Otte AP; Postmus PE; Meijer CJ; Raaphorst FM; Smit EF Lung Cancer; 2005 Jun; 48(3):299-306. PubMed ID: 15892997 [TBL] [Abstract][Full Text] [Related]
5. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer. Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196 [TBL] [Abstract][Full Text] [Related]
6. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding. Prall F; Ostwald C; Weirich V; Nizze H Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092 [TBL] [Abstract][Full Text] [Related]
9. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590 [TBL] [Abstract][Full Text] [Related]
10. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis. Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963 [TBL] [Abstract][Full Text] [Related]
11. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues. Llanos AA; Dumitrescu RG; Brasky TM; Liu Z; Mason JB; Marian C; Makambi KH; Spear SL; Kallakury BV; Freudenheim JL; Shields PG Carcinogenesis; 2015 Jan; 36(1):60-7. PubMed ID: 25344837 [TBL] [Abstract][Full Text] [Related]
12. Electron microscopy evidence that cytoplasmic localization of the p16(INK4A) "nuclear" cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas. Evangelou K; Bramis J; Peros I; Zacharatos P; Dasiou-Plakida D; Kalogeropoulos N; Asimacopoulos PJ; Kittas C; Marinos E; Gorgoulis VG Biotech Histochem; 2004 Feb; 79(1):5-10. PubMed ID: 15223748 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839 [TBL] [Abstract][Full Text] [Related]
14. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma. Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Lerma E; Esteller M; Herman JG; Prat J Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817 [TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Grote HJ; Schmiemann V; Geddert H; Rohr UP; Kappes R; Gabbert HE; Böcking A Int J Cancer; 2005 Sep; 116(5):720-5. PubMed ID: 15849750 [TBL] [Abstract][Full Text] [Related]
17. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681 [TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Salvesen HB; Das S; Akslen LA Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma. van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]